Zobrazeno 1 - 5
of 5
pro vyhledávání: '"MATT DOWNS"'
Autor:
Paige Colley, Karen Schouten, Nicole Chabot, Matt Downs, Lauren Anstey, Marc S. Moulin, Ruth E. Martin
Publikováno v:
International Review of Research in Open and Distributed Learning, Vol 20, Iss 3 (2019)
Approximately one in 10 employed Canadians worked in health care and social services in 2016. Health professionals perceive life-long learning as an important element of professional life and value flexibility in their continuing education activities
Externí odkaz:
https://doaj.org/article/7914268fe8f94c4793aadcf6cbed50a1
Autor:
Carryn M. Anderson, Christopher M. Lee, Deborah Saunders, Amarinthia E. Curtis, Neal E. Dunlap, Chaitali Nangia, Arielle S. Lee, Philip Kovoor, Voichita Bar-Ad, Abhinand V. Pedadda, Jon Holmlund, Matt Downs, Stephen T. Sonis
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 114:416-421
Avasopasem manganese (GC4419), an investigational selective dismutase mimetic radioprotector, reduced duration, incidence, and severity of severe oral mucositis (World Health Organization grade 3-4) in a phase 2b, randomized, double-blind trial of pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76e227ae3ab0d86631fdc455fb24daab
https://doi.org/10.1016/j.ijrobp.2022.06.063
https://doi.org/10.1016/j.ijrobp.2022.06.063
Autor:
Tran M. Nguyen, Matt Downs, Neil Bennett, Vitaliy Matyushenko, Harumasa Nakamura, Damjan Osredkar, Shiwen Wu, Nathalie Goemans, Anna Ambrosini, Rahsa El Sherifc, Craig Campbell
Publikováno v:
Journal of Rare Diseases Research & Treatment. 7:5-15
Background: TREAT-NMD is a global neuromuscular (NM) organization, created to enhance infrastructure to facilitate novel therapeutics reaching patients. One main activity is aimed at supporting NM disease registries. These rare disease registries are
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::778a005b4284a010ba8d2a43fdaa37f8
https://doi.org/10.29245/2572-9411/2022/2.1204
https://doi.org/10.29245/2572-9411/2022/2.1204
Publikováno v:
Chest. 162:A2254
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::72b285a6058048c70e789f374a4d36cd
https://doi.org/10.1016/j.chest.2022.08.1866
https://doi.org/10.1016/j.chest.2022.08.1866
Autor:
Jon Holmlund, Jeffrey Mark Brill, Christopher M. Lee, Deborah Saunders, Stephen T. Sonis, Matt Downs, Carryn M. Anderson
Publikováno v:
Journal of Clinical Oncology. 37:TPS6096-TPS6096
TPS6096 Background: Approximately 70% of patients receiving intensity-modulated radiotherapy (IMRT) plus cisplatin for locally advanced head and neck cancer (HNC) develop SOM, defined as WHO Grade 3 or 4, which limits patients' ability to eat solids
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c848cc88836bc168a34eb9fbb46cd172
https://doi.org/10.1200/jco.2019.37.15_suppl.tps6096
https://doi.org/10.1200/jco.2019.37.15_suppl.tps6096